These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23265285)

  • 61. Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
    Cappelletti C; Maes A; Rossman K; Gillen M; LaForce C; Kerwin EM; Reisner C
    Clin Drug Investig; 2021 Jun; 41(6):579-590. PubMed ID: 34089147
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial.
    Patel M; Pilcher J; Travers J; Perrin K; Shaw D; Black P; Weatherall M; Beasley R
    J Allergy Clin Immunol Pract; 2013 Jan; 1(1):83-91. PubMed ID: 24229826
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of extreme temperatures on drug delivery of albuterol sulfate hydrofluoroalkane inhalation aerosols.
    Hoye WL; Mogalian EM; Myrdal PB
    Am J Health Syst Pharm; 2005 Nov; 62(21):2271-7. PubMed ID: 16239418
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Teaching time for metered-dose inhalers in the emergency setting.
    Numata Y; Bourbeau J; Ernst P; Duquette G; Schwartzman K
    Chest; 2002 Aug; 122(2):498-504. PubMed ID: 12171822
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma.
    LaForce C; Taveras H; Iverson H; Shore P
    Allergy Asthma Proc; 2017 Jan; 38(1):28-37. PubMed ID: 28052799
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience.
    Salyer JW; DiBlasi RM; Crotwell DN; Cowan CA; Carter ER
    Respir Care; 2008 Mar; 53(3):338-45. PubMed ID: 18291050
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine.
    Ahrens RC; Hendeles L; Clarke WR; Dockhorn RJ; Hill MR; Vaughan LM; Lux C; Han SH
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1238-43. PubMed ID: 10508813
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
    Goldberg J; Böhning W; Schmidt P; Freund E
    Respir Med; 2000 Oct; 94(10):948-53. PubMed ID: 11059947
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction.
    Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH
    Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Assessment of patient performance of the HandiHaler compared with the metered dose inhaler four weeks after instruction.
    Dahl R; Backer V; Ollgaard B; Gerken F; Kesten S
    Respir Med; 2003 Oct; 97(10):1126-33. PubMed ID: 14561020
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effect of a holding chamber on albuterol metered-dose inhaler product differences.
    Johnson JL; Guthrie D; Hyde J; Hanson T; Karlage K; Myrdal PB
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):246-50. PubMed ID: 27613457
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does parental involvement in pediatric emergency department asthma treatment affect home management?
    Hussain-Rizvi A; Kunkov S; Crain EF
    J Asthma; 2009 Oct; 46(8):792-5. PubMed ID: 19863282
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Improving asthma management: the case for mandatory inclusion of dose counters on all rescue bronchodilators.
    Conner JB; Buck PO
    J Asthma; 2013 Aug; 50(6):658-63. PubMed ID: 23544966
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
    Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
    Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma.
    Ratnayake A; Taveras H; Iverson H; Shore P
    Allergy Asthma Proc; 2016 Sep; 37(5):370-5. PubMed ID: 27523719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of a non-chlorofluorocarbon formulation of cromolyn sodium (Intal) metered-dose inhaler versus the chlorofluorocarbon formulation in the treatment of adult patients with asthma: a controlled trial.
    Blumenthal MN; Casale TB; Fink JN; Uryniak T; Casty FE
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):7-13. PubMed ID: 9449494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.